Representative before the EPO

Employment test 501 - 1000 employees
Company dna marks and clerk llp
operating since 1887
Headquarter in London and 16 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading

Representative before the EPO

Company dna marks and clerk luxembourg llp
no operation time available
Headquarter in Luxembourg
active in Legal Services

Hilton David Lord has worked on the following 43 EPO patent applications which have been published in the last five years:

EP11714488

IMMUNE THERAPY

IPC classification:
A61K 39/21, C07K 14/16
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11787409

EXTRUSION TAP TOP BEAM CLAMP

IPC classification:
F16L 3/24
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12190994

Heat emitting device

IPC classification:
F28D 1/04, F28D 1/047, F28F 1/22, F28F 21/06
Agent:
Hilton David Lord, Marks & Clerk LLP
Agent:
Hoffmann Eitle PartmbB
Status:
EXAMINATION REQUESTED
EP10860584

AGENTS AND METHODS FOR INHIBITING HUMAN PLURIPOTENT STEM CELL GROWTH

IPC classification:
C12N 5/02, C12N 5/0735
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP12752878

PROCESS FOR REDUCTION OF -ACYLOXY SULFIDE DERIVATIVES

IPC classification:
C07C 213/10, C07C 215/08, C07C 317/24
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13166147

Selective apoptotic induction in cancer cells including activation of procaspase-3

IPC classification:
A61K 31/495, A61P 35/00, C07D 295/15, G01N 33/574
Applicant:
Board of Trustees of the University of Illinois
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12713264

ARTICLE WITH A JOINT BETWEEN AN ALUMINIUM COMPONENT AND A HARD METAL, THE COMPRISING AN ALUMINIUM BRONZE TRANSITION PIECE WELDED TO THE ALUMINIUM COMPONENT : METHOD OF JOINING SUCH ARTICLE

IPC classification:
B23K 15/00, B23K 15/04, B23K 15/06, B23K 33/00, C22C 9/01
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12182095

Kappa-Opiate Agonists For The Treatment Of Diarrhea-Predominant and Alternating Irritable Bowel Syndrome

IPC classification:
A61K 31/40
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11738959

ANTIBODY DERIVATIVES

IPC classification:
A61K 39/395, C07K 16/30, C12N 9/88
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13159810

Method and apparatus for rehydration of lyophilized biologic materials

IPC classification:
A61F 2/00, A61J 1/10, B65D 81/00
Applicant:
C.R. Bard Inc.
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
The patent has been granted
EP11187408

Heat emitting device

IPC classification:
F28D 1/04, F28F 21/06
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13191140

Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

IPC classification:
C12N 5/0735, C12N 5/074
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13159712

Endocrine precursor cells, pancreatic hormone-expressing cells and methods of production

IPC classification:
C12N 5/071, C12N 5/0735
Agent:
Hilton David Lord, Marks & Clerk LLP
Agent:
Vossius & Partner Patentanwälte Rechtsanwälte mbB
Status:
EXAMINATION REQUESTED
EP11785513

PROCESS FOR PURIFYING ZINC OXIDE

IPC classification:
C22B 19/20
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12832188

BIORESORBABLE DRUG DELIVERY MATRICES BASED ON CROSS-LINKED POLYSACCHARIDES, DOSAGE FORMS DESIGNED FOR DELAYED/CONTROLLED RELEASE

IPC classification:
A61K 9/00
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12789648

SOLID FORMS OF A PHARMACEUTICALLY ACTIVE SUBSTANCE

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13185755

Human disc tissue

IPC classification:
A61K 35/32, A61P 19/00, C12N 5/02, C12N 5/077
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP12745360

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

IPC classification:
A61K 31/437, A61K 31/506, A61K 31/5377, C07D 471/04
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP12860237

KNEADING-TYPE ANTISTATIC AGENT, THERMOPLASTIC RESIN COMPOSITION INCLUDING SAID AGENT, AND MOLDED ARTICLE

IPC classification:
C08F 290/06, C08F 299/02, C08L 55/00, C08L 101/00, C09K 3/16
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13700757

NEUROLOGICAL THERAPIES

IPC classification:
A61K 38/16, A61P 25/16, A61P 25/28, A61P 27/06
Applicant:
University of Bologna (Università di Bologna – Alma mater studiorum)
Agent:
Hilton David Lord, Marks & Clerk LLP
Agent:
Valentina Predazzi, Società Italiana Brevetti SpA
Status:
EXAMINATION IN PROGRESS
EP11176851

Polyelectrolyte films and their preparation

IPC classification:
H01B 1/06
Agent:
Hilton David Lord, Marks & Clerk (Luxembourg) LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13752396

DEVICES, METHODS, AND TEST KITS FOR ELECTRONIC ANALYTE ASSAYING

IPC classification:
G01N 33/00, G01N 35/00
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13754866

SALTS OF POTASSIUM ATP CHANNEL OPENERS AND USES THEREOF

IPC classification:
A61K 31/38, A61K 31/549, A61P 3/00, A61P 9/00
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13711848

BIOCONTROL

IPC classification:
A01K 67/033, C12N 15/85
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13714152

COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR

IPC classification:
A61K 31/436, A61K 31/437, A61K 31/4545, A61K 31/506, A61K 45/06, A61P 19/08, A61P 19/10, A61P 25/00, A61P 25/28, A61P 25/30, A61P 35/00
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11703116

METHODS AND COMPOSITIONS FOR PROFILING RNA MOLECULES

IPC classification:
C12Q 1/68
Agent:
Hilton David Lord, Marks & Clerk (Luxembourg) LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13778322

START-UP TORCH

IPC classification:
F27B 1/16, H05H 1/26
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP13193567

Methods for treating a variety of diseases and conditions, and compounds useful therefor

IPC classification:
A01N 37/18, A61K 31/16
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13784580

SELF ADHERING IMPLANTABLE MESH PROSTHESIS WITH REDUCED INSERTION PROFILE

IPC classification:
A61B 17/08, A61F 2/00, A61F 2/02, A61F 13/00
Applicant:
C.R. Bard Inc.
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13727790

SYNTHESIS OF PYRROLO [2, 3 - B]PYRIDINES

IPC classification:
C07D 471/04
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP13781806

AIR CONDITIONER

IPC classification:
F24F 1/00, F24F 11/02
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED
EP14162810

Method for decolorization of a dyed polyester fiber

IPC classification:
D06P 5/13
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
APPLICATION WITHDRAWN
EP12879324

COMPOSITIONS AND METHODS FOR TREATMENT OF NEUROPSYCHOLOGICAL DEFICITS

IPC classification:
A01N 37/02
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753421

BIOMARKERS

IPC classification:
C07K 14/47, G01N 33/564
Agent:
Hilton David Lord, Marks & Clerk LLP
Agent:
Valentina Predazzi, Società Italiana Brevetti SpA
Status:
EXAMINATION IN PROGRESS
EP13831502

ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINS

IPC classification:
A61K 39/395, C07K 19/00, C12N 5/071, C12P 21/08
Applicant:
Seattle Genetics, Inc.
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11747929

ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF

IPC classification:
A61K 31/137, A61K 31/167, A61K 31/445, A61P 5/26, A61P 15/00, A61P 43/00, C07D 221/12, C07D 295/155
Agent:
Elizabeth Ann Dawson, Pearl Cohen Zedek Latzer Baratz UK LLP
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13792945

DERMAL COMPOSITIONS CONTAINING UNNATURAL HYGROSCOPIC AMINO ACIDS

IPC classification:
A61K 8/44, A61K 9/00, A61K 31/198, A61P 17/00, A61Q 19/00
Applicant:
University of Reading
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
GRANT OF PATENT INTENDED
EP15171526

PROPANE-I-SULFONIC ACID {3- [5- (4- CHLORO-PHENYL) -1H-PYRROLO [2, 3-B} PYRIDINE-3-CARBONYL] -2, 4-DIFLUORO-PHENYL} -AMIDE COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 31/437, A61P 35/00, C07D 471/04
Applicant:
F. Hoffmann-La Roche AG
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION REQUESTED
EP14708981

CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS

IPC classification:
C12N 5/00, C12N 5/071
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14717903

3-DIMENSIONAL LARGE CAPACITY CELL ENCAPSULATION DEVICE ASSEMBLY

IPC classification:
A61F 2/02
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP14721621

IN VITRO DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO PANCREATIC ENDODERM CELLS (PEC) AND ENDOCRINE CELLS

IPC classification:
C12N 5/0735
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
EXAMINATION IN PROGRESS
EP11753944

COMBINATION THERAPY FOR TREATING BREAST CANCER

IPC classification:
A01N 43/54, A61K 31/425, A61K 31/505, A61P 35/00
Applicant:
Genzyme Corporation
Agent:
Adamson Jones
Agent:
Hilton David Lord, Marks & Clerk LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11761230

MOSQUITOCIDAL XENORHABDUS, LIPOPEPTIDE AND METHODS

IPC classification:
A01N 37/46, A01N 63/02, A01P 7/04, A61K 35/74, A61K 38/03
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Multiple attorneys, Marks & Clerk LLP
Status:
PATENT GRANTED

Please Sign in to use this feature